Authors
Malik E Juweid, Sigrid Stroobants, Otto S Hoekstra, Felix M Mottaghy, Markus Dietlein, Ali Guermazi, Gregory A Wiseman, Lale Kostakoglu, Klemens Scheidhauer, Andreas Buck, Ralph Naumann, Karoline Spaepen, Rodney J Hicks, Wolfgang A Weber, Sven N Reske, Markus Schwaiger, Lawrence H Schwartz, Josee M Zijlstra, Barry A Siegel, Bruce D Cheson
Publication date
2007/2/10
Journal
Journal of clinical oncology
Volume
25
Issue
5
Pages
571-578
Publisher
American Society of Clinical Oncology
Description
Purpose
To develop guidelines for performing and interpreting positron emission tomography (PET) imaging for treatment assessment in patients with lymphoma both in clinical practice and in clinical trials.
Methods
An International Harmonization Project (IHP) was convened to discuss standardization of clinical trial parameters in lymphoma. An imaging subcommittee developed consensus recommendations based on published PET literature and the collective expertise of its members in the use of PET in lymphoma. Only recommendations subsequently endorsed by all IHP subcommittees were adopted.
Recommendations
PET after completion of therapy should be performed at least 3 weeks, and preferably at 6 to 8 weeks, after chemotherapy or chemoimmunotherapy, and 8 to 12 weeks after radiation or chemoradiotherapy. Visual assessment alone is adequate for …
Total citations
Scholar articles
ME Juweid, S Stroobants, OS Hoekstra, FM Mottaghy… - Journal of clinical oncology, 2007